Literature DB >> 19636651

Physiologic risk assessment in stable ischemic heart disease: still superior to the anatomic angiographic approach.

Alessia Gimelli, Paolo Marzullo, Daniele Rovai.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19636651     DOI： 10.1007/s12350-009-9116-7

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  22 in total

1.  Lessons learnt from the autopsies of 445 cases of sudden cardiac death in adults.

Authors:  Manolis Michalodimitrakis; Anna Mavroforou; Athanasios D Giannoukas
Journal:  Coron Artery Dis       Date:  2005-09       Impact factor: 1.439

2.  Independent and incremental prognostic value of tests performed in hierarchical order to evaluate patients with suspected coronary artery disease. Validation of models based on these tests.

Authors:  S G Pollock; R D Abbott; C A Boucher; G A Beller; S Kaul
Journal:  Circulation       Date:  1992-01       Impact factor: 29.690

3.  The clinical characteristics and investigations planned in patients with stable angina presenting to cardiologists in Europe: from the Euro Heart Survey of Stable Angina.

Authors:  Caroline A Daly; Felicity Clemens; Jose L Lopez Sendon; Luigi Tavazzi; Eric Boersma; Nicholas Danchin; Francois Delahaye; Anselm Gitt; Desmond Julian; David Mulcahy; Witold Ruzyllo; Kristian Thygesen; Freek Verheugt; Kim M Fox
Journal:  Eur Heart J       Date:  2005-03-18       Impact factor: 29.983

4.  Prognostic importance of a clinical profile and exercise test in medically treated patients with coronary artery disease.

Authors:  D A Weiner; T J Ryan; C H McCabe; B R Chaitman; L T Sheffield; J C Ferguson; L D Fisher; F Tristani
Journal:  J Am Coll Cardiol       Date:  1984-03       Impact factor: 24.094

5.  Prediction of mortality using dobutamine echocardiography.

Authors:  T H Marwick; C Case; S Sawada; C Rimmerman; P Brenneman; R Kovacs; L Short; M Lauer
Journal:  J Am Coll Cardiol       Date:  2001-03-01       Impact factor: 24.094

6.  Paradoxical increase in lumen size during progression of coronary atherosclerosis: observations from the REVERSAL trial.

Authors:  Ilke Sipahi; E Murat Tuzcu; Paul Schoenhagen; Stephen J Nicholls; Michael S Chen; Timothy Crowe; Aaron B Loyd; Samir Kapadia; Steven E Nissen
Journal:  Atherosclerosis       Date:  2006-01-20       Impact factor: 5.162

7.  Stress/Rest Myocardial Perfusion Abnormalities by Gated SPECT: Still the Best Predictor of Cardiac Events in Stable Ischemic Heart Disease.

Authors:  Alessia Gimelli; Giuseppe Rossi; Patrizia Landi; Paolo Marzullo; Giorgio Iervasi; Antonio L'abbate; Daniele Rovai
Journal:  J Nucl Med       Date:  2009-03-16       Impact factor: 10.057

8.  Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry.

Authors:  M Emond; M B Mock; K B Davis; L D Fisher; D R Holmes; B R Chaitman; G C Kaiser; E Alderman; T Killip
Journal:  Circulation       Date:  1994-12       Impact factor: 29.690

9.  Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease.

Authors:  A S Iskandrian; S C Chae; J Heo; C D Stanberry; V Wasserleben; V Cave
Journal:  J Am Coll Cardiol       Date:  1993-09       Impact factor: 24.094

10.  Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.

Authors:  Leslee J Shaw; Daniel S Berman; David J Maron; G B John Mancini; Sean W Hayes; Pamela M Hartigan; William S Weintraub; Robert A O'Rourke; Marcin Dada; John A Spertus; Bernard R Chaitman; John Friedman; Piotr Slomka; Gary V Heller; Guido Germano; Gilbert Gosselin; Peter Berger; William J Kostuk; Ronald G Schwartz; Merill Knudtson; Emir Veledar; Eric R Bates; Benjamin McCallister; Koon K Teo; William E Boden
Journal:  Circulation       Date:  2008-02-11       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.